Polymerase Chain Reaction (PCR) Market Revenue to Double by 2026, on the back of Technological Advancements in Healthcare Industry
Technological advancements in molecular biology, life sciences, and biotechnology have brought paradigm shifts in healthcare diagnostics, drug discovery, personalized medicines, forensic sciences, and clinical research & development. Polymerase Chain Reaction (PCR) is an important breakthrough in this respect. PCR is an integral part of the pharmaceutical, biotechnology and life science industries for developing assays, test kits & solutions, and culture media in the tissue culture industry.
Thus, an increase in pharmaceutical R&D budgets by governments and private players is anticipated to boost growth prospects of the global polymerase chain reaction (PCR) market in the future. Also, rise in prevalence of chronic and infectious diseases is projected to push the demand for PCR solutions during the forecast period (2020-2026). The global PCR market is poised to expand nearly 2X and reach US$ 7.0 Bn by 2026-end.
Pharmaceutical and Biotechnology Industries Emerge as Key End Users
Pharmaceutical and biotechnology Industries are poised to capture a major chunk of the global PCR market. Increasing test volumes and laboratory automation are projected to drive demand for PCR services in the pharmaceutical and biotechnology industries. Rising investments in R&D of genetic engineering and competition in the discovery of new drugs for diseases such as HIV-AIDS and cancer will also boost growth prospects. Adoption of PCR in pharmaceutical and biotechnology industries is anticipated to grow impressively at a CAGR of 8.6% in the forecast period.
The demand for PCR in clinical diagnostic labs and hospitals is forecast to surge at a significant rate. Increased awareness about molecular diagnostic applications of the PCR technique in cancer and HIV-AIDS detection, laboratory automation and high prevalence of infectious diseases are projected to boost the adoption of PCR solutions in clinical & diagnostic labs and hospitals during the forecast period. The segment is anticipated to record a CAGR of 8.8% through 2026.
For better understanding of revenue contribution of each end user to the PCR market, ask an exert analyst
North America to Reign Supreme, Asia Pacific Market to Register an Uptick
North America is foreseen to remain the kingpin of the global PCR market. This is attributed to adoption of new biotechnologies, increased awareness about PCR products, significant fund allocation for research in national budgets, early availability of advanced technologies, and a rise in R&D activities in the region. For example, the advent of multifaceted synthetic and bioprospected polymerases and development of symbiotic sequencing technologies have transformed the PCR market in North America. The regional market is projected to record a CAGR of 7.5% and account for nearly half of the global market value by 2026.
Asia Pacific’s PCR market is anticipated to experience healthy growth during the forecast period. This is primarily due to improvements in healthcare infrastructure, a rise in public and private investment in life science research, and technological advancements in the healthcare industry in developing economies. Significant expansion of market players in Asia Pacific through licensing and distribution agreements with local players is also anticipated to fuel the PCR market growth. A prolific CAGR of 9.7% is projected for the Asia-Pacific region for the predefined timeframe.
For more valuable insights on the regional markets for PCR, request a report sample
Product Launches and R&D Remain Important Growth Strategies
The global PCR market is consolidated, with leading players such as Roche Diagnostics, Abbott Laboratories and Thermo Fishers Scientific accounting for the maximum share. However, new entrants are finding a marketplace, owing to the introduction of advanced technologies.
F. Hoffmann La- Roche AG, one of the dominant market players, offers diverse products and solutions in various fields including clinical chemistry and immunoassay, molecular diagnostics, and tissue diagnostics. The company specializes in the provision of real-time PCR and includes products such as Cobas S 201, CobasTaqScreen MPX Test, Cobas 4800 System and LightCylinder MRSA Advanced Test.
Competitors, such as Becton, Dickinson and Company, also have a market presence via focus on R&D and new product launches. The company offers Real Time PCR systems, PCR assays and PCR Cloning Kits. Some products include the BD MAX System, BD-Qzyme Assays and BD In-Fusion.
COVID-19 Impact Assessment
With the number of coronavirus cases growing exponentially per day and no vaccine or drug across the horizon, healthcare providers have their hands full. In the wake of such rapidly increasing cases, the demand for testing kits has surged. In India, the number of tests for the detection of the COVID-19 exceeded the 4 million mark as of June 2020. Testing capacity has been increased to 140,000 per day across more than 600 government and private laboratories during this period. Amongst all the testing mechanisms which are currently employed, PCR remains the most prevalent. The test is being extensively employed to detect the presence of the virus and to determine the degree of infection within the patient.
A high degree of accuracy and reliability of testing data is what makes the RT-PCR approach highly popular amongst medical practitioners to detect COVID-19 cases. The testing typically takes 4 to 8 hours while the results are delivered almost 24 hours after the testing has been conducted. Due to this time lag, healthcare settings are looking for alternative testing mechanisms capable of delivering the results in a shorter timeframe. Nevertheless, the RT-PCR testing is projected to maintain an upward sloping curve until the time the pandemic is here to stay. Additionally, home testing kits are being rolled out to facilitate unfettered access to rapid and safe COVID-19 testing.
The Analyst’s Viewpoint
“Testing kit manufacturers are exploring multifarious ways to enhance the quality of RT-PCR tests, given the high degree of time-lag between the testing and results. Emphasis on maintaining the geometric amplification of the target gene is being stressed upon to deliver consistent results throughout the testing process, paving way for more accurate data.”
Global Polymerase Chain Reaction Market: Scope of the Report
The recent study undertaken by Fact.MR on the global polymerase chain reaction (PCR) market incorporates an unbiased analysis of the key market dynamics such as the prominent drivers, restraints and opportunities shaping market growth during the forecast period 2020-2026. The market has been analyzed in great detail, providing crucial information on the revenue and growth prospects of each segment, which include product and end users.
Both the aforementioned segments have been regionally profiled across the following geographies: North America, Europe, Asia Pacific, Latin America and Rest of the World. In the final section, the report elaborates on the competition landscape, providing details about prominent market players, their revenue and market shares, important product launches and collaborations and a SWOT analysis of each market player. Overall, the report presents an optimistic scenario of the market growth prospects.
Global Polymerase Chain Reaction (PCR) Market - Scope of the Report
The recent study by Fact.MR on the global polymerase chain reaction (PCR) market offers a 6-year forecast for the period of 2020-2026. The study analyzes crucial trends that are currently determining the global polymerase chain reaction (PCR) market growth. This report explicates on vital dynamics such as drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with the provision of polymerase chain reaction (PCR) solutions. The study also provides dynamics that are responsible for influencing the future status of the global polymerase chain reaction (PCR) market over the forecast period.
A detailed assessment of the global polymerase chain reaction (PCR) market value chain, business execution, and supply chain across different regional markets has been covered in the report. A list of prominent companies operating in the global polymerase chain reaction (PCR) market along with their product portfolio enhances the reliability of this comprehensive research study.
Global Polymerase Chain Reaction (PCR) Market: Report Summary
The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in the global polymerase chain reaction (PCR) market.
A comprehensive estimate of the global polymerase chain reaction (PCR) market has been provided through an optimistic as well as a conservative scenario, taking into account the adoption of polymerase chain reaction (PCR) during the forecast period. Price point comparison by region with global average price is also considered in the study.
Global Polymerase Chain Reaction (PCR) Market: Key Segmentation
Fact.MR has studied the global polymerase chain reaction (PCR) market with detailed segmentation on the basis of product, end user and region.
|
Product |
End User |
Region |
|
Instruments: Standard PCR Systems RT PCR Systems Digital PCR Systems |
Pharmaceutical & Biotechnology Industries Clinical Diagnostics Labs and Hospitals |
North America
Europe |
|
Reagents |
Academic and Research Organizations |
Asia Pacific |
|
Consumables |
Others |
Latin America |
|
|
|
Rest of the World |
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”
Global Polymerase Chain Reaction (PCR) Market: Size Evaluation
The global polymerase chain reaction (PCR) market has been analyzed for each market segment, in terms of value (US$ Mn).
Market estimates at global and regional levels for polymerase chain reaction are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent polymerase chain reaction (PCR) market segments along with market attractiveness evaluation has been incorporated in the report.
Global Polymerase Chain Reaction (PCR) Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the global polymerase chain reaction (PCR) report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic, and business environment outlook), which are expected to have a momentous influence on the growth of the global polymerase chain reaction (PCR) market during the forecast period.
Country-specific valuation on demand for polymerase chain reaction (PCR) has been offered for each regional market, along with the market scope, estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value & volume for emerging countries has also been included in the report.
Global Polymerase Chain Reaction (PCR) Market: In-Depth Analysis on Competitive Landscape
The report sheds light on the leading players in the global polymerase chain reaction (PCR) market along with their detailed profiles. Essential and up-to-date data and information related to the market performers, who are principally engaged in the provision of polymerase chain reaction (PCR) solutions, have been presented with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permit the report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the global polymerase chain reaction (PCR) market. Prominent manufacturers with established market presence in the global polymerase chain reaction (PCR) market are F. Hoffmann- La Roche AG, Thermo Fisher Scientific Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Qiagen N.V., Becton, Dickinson and Company, Siemens Healthcare Gmbh (Siemens AG) and bioMerieux SA to name a few.
1. Market Overview
1.1. Market Coverage / Taxonomy
1.2. Market Definition / Scope / Limitations
2. Market Risks and Trends Assessment
2.1. Risk Assessment
2.1.1. COVID-19 Crisis and Impact on PCR Demand
2.1.2. COVID-19 Crisis and Impact on PCR Cost
2.1.3. COVID-19 Impact Benchmark with Previous Crisis
2.1.3.1. Change in PCR Demand
2.1.3.2. Before and After COVID-19 Crisis (Projected)
2.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual)
2.1.3.4. Change in Demand post Recovery Period (After Each Crisis)
2.1.4. Impact on Market Value (US$ Mn)
2.1.4.1. Likely Loss of Value in 2020
2.1.4.2. Mid-term and Long Term Forecast
2.1.4.3. Quarter by Quarter Demand and Recovery Assessment
2.1.5. Anticipated Demand and Value Recovery Curve
2.1.5.1. Likelihood of U-Shape Recovery
2.1.5.2. Likelihood of L-Shape Recovery
2.1.6. Recovery Period Assessment by Key Countries
2.1.7. Recovery Assessment by Key Market Segments
2.1.8. Action Points and Recommendation
2.2. Key Trends Impacting the Market
3. Market Background and Foundation Data Points
3.1. Global Healthcare Market Overview
3.2. Healthcare Spending Analysis, By Key Countries
3.3. Recent Developments in PCR Industry
3.4. Growth and Development Patterns in PCR Market
3.5. Market White Space Assessment And Opportunity Analysis
3.6. Recent Development in PCR Market, By Market Players
3.7. Competitive Scenario and Trends
3.7.1. PCR Market Concentration Rate
3.7.2. List of Emerging, Prominent and Leading Players
3.7.3. Mergers & Acquisitions
3.8. Scenario Forecast
and in optimistic, likely, and conservative market conditions)
3.9. Policy and Regulatory Landscape
3.10. Macro-Economic Factors
3.11. Forecast Factors - Relevance & Impact
3.12. Market Dynamics
3.12.1. Market Driving Factors and Impact Assessment
3.12.2. Prominent Market Challenges and Impact Assessment
3.12.3. PCR Market Opportunities
3.12.4. Prominent Trends in the Global Market & Their Impact Assessment
4. Key Success Factors
4.1. PCR Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Others (Discussed in Report)
5. Global PCR Market Value Analysis 2015-2019 and Forecast, 2020-2026
5.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
5.2. Current and Future Market Value (US$ Mn) Projections, 2020-2026
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global PCR Market Analysis 2015-2019 and Forecast 2020-2026, By Product
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2019
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2020 - 2026
6.3.1. Instruments
6.3.1.1. Standard PCR
6.3.1.2. RT PCR
6.3.1.3. Digital PCR
6.3.2. Reagents
6.3.3. Consumables
6.4. Market Attractiveness Analysis By Product
7. Global PCR Market Analysis 2015-2019 and Forecast 2020-2026, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020 - 2026
7.3.1. Pharmaceutical and Biotechnology Industries
7.3.2. Clinical Diagnostics Labs and Hospitals
7.3.3. Academic and Research Organizations
7.3.4. Others
7.4. Market Attractiveness Analysis By End User
8. Global PCR Market Analysis 2015-2019 and Forecast 2020-2026, by Region
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2019
8.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2026
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Market Attractiveness Analysis By Region
9. North America PCR Market Analysis 2015-2019 and Forecast 2020-2026
9.1. Introduction
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
9.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 - 2026
9.4.1. By Country
9.4.1.1. U.S.
9.4.1.2. Canada
9.4.2. By Product
9.4.3. By End User
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Product
9.5.3. By End User
10. Latin America PCR Market Analysis 2015-2019 and Forecast 2020-2026
10.1. Introduction
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
10.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 - 2026
10.4.1. By Country
10.4.1.1. Brazil
10.4.1.2. Mexico
10.4.1.3. Rest of Latin America
10.4.2. By Product
10.4.3. By End User
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Product
10.5.3. By End User
11. Europe PCR Market Analysis 2015-2019 and Forecast 2020-2026
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
11.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 - 2026
11.4.1. By Country
11.4.1.1. Germany
11.4.1.2. France
11.4.1.3. Italy
11.4.1.4. Spain
11.4.1.5. U.K.
11.4.1.6. Russia
11.4.1.7. Rest of Europe
11.4.2. By Product
11.4.3. By End User
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product
11.5.3. By End User
12. Asia Pacific PCR Market Analysis 2015-2019 and Forecast 2020-2026
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
12.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 - 2026
12.4.1. By Country
12.4.1.1. China
12.4.1.2. Japan
12.4.1.3. India
12.4.1.4. Australia & New Zealand
12.4.1.5. Rest of Asia Pacific
12.4.2. By Product
12.4.3. By End User
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product
12.5.3. By End User
13. Middle East and Africa PCR Market Analysis 2015-2019 and Forecast 2020-2026
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2019
13.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 - 2026
13.4.1. By Country
13.4.1.1. GCC Countries
13.4.1.2. South Africa
13.4.1.3. Rest of Middle East and Africa
13.4.2. By Product
13.4.3. By End User
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product
13.5.3. By End User
14. Market Structure Analysis
14.1. Market Analysis by Tier of Companies
14.2. Market Concentration
14.3. Market Share Analysis of Top Players
14.4. Market Presence Analysis
14.4.1. By Regional footprint of Players
14.4.2. Product footprint by Players
14.4.3. Channel footprint by Players
15. Competition Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Competition Deep Dive (Indicative List)
15.3.1. Bio-Rad Laboratories, Inc.
15.3.1.1. Overview
15.3.1.2. Product Portfolio
15.3.1.3. Sales Footprint
15.3.1.4. Strategy Overview
15.3.2. Qiagen N.V.
15.3.2.1. Overview
15.3.2.2. Product Portfolio
15.3.2.3. Sales Footprint
15.3.2.4. Strategy Overview
15.3.3. F. Hoffmann-La Roche AG
15.3.3.1. Overview
15.3.3.2. Product Portfolio
15.3.3.3. Sales Footprint
15.3.3.4. Strategy Overview
15.3.4. Thermo Fisher Scientific, Inc.
15.3.4.1. Overview
15.3.4.2. Product Portfolio
15.3.4.3. Sales Footprint
15.3.4.4. Strategy Overview
15.3.5. Becton, Dickinson and Company
15.3.5.1. Overview
15.3.5.2. Product Portfolio
15.3.5.3. Sales Footprint
15.3.5.4. Strategy Overview
15.3.6. Abbott
15.3.6.1. Overview
15.3.6.2. Product Portfolio
15.3.6.3. Sales Footprint
15.3.6.4. Strategy Overview
15.3.7. Siemens Healthcare GmbH (Siemens AG)
15.3.7.1. Overview
15.3.7.2. Product Portfolio
15.3.7.3. Sales Footprint
15.3.7.4. Strategy Overview
15.3.8. BioMérieux SA
15.3.8.1. Overview
15.3.8.2. Product Portfolio
15.3.8.3. Sales Footprint
15.3.8.4. Strategy Overview
15.3.9. Danaher Corporation
15.3.9.1. Overview
15.3.9.2. Product Portfolio
15.3.9.3. Sales Footprint
15.3.9.4. Strategy Overview
15.3.10. Agilent Technologies
15.3.10.1. Overview
15.3.10.2. Product Portfolio
15.3.10.3. Sales Footprint
15.3.10.4. Strategy Overview
15.3.11. Other Prominent Players
15.3.11.1. Overview
15.3.11.2. Product Portfolio
15.3.11.3. Sales Footprint
15.3.11.4. Strategy Overview
16. Assumptions and Acronyms Used
17. Research Methodology
Fact.MR offers custom research services that help clients to get specific research solutions
Related reports
We are committed towards customer satisfaction and quality service.
Polymerase Chain Reaction (PCR) Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2020 to 2026